2005N-0510 | Anti-Counterfeit Drug Initiative Workshop and Vendor Display | |||||||||||||||||||||||
FDA Comment Number : | EC4 | |||||||||||||||||||||||
Submitter : | Mr. David Dillon | Date & Time: | 02/27/2006 01:02:17 | |||||||||||||||||||||
Organization : | Verify Brand | |||||||||||||||||||||||
Category : | Private Industry | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
The attached research report from the Los Alamos National Labs Vulnerability Assessment Team asks very interesting questions of existing anti- counterfeiting technology and makes important recommendations in terms of authentication methodologies that can be used at any point in the supply chain, including, if desired, the end consumer. | ||||||||||||||||||||||||
2005N-0510-EC4-Attach-1.PDF |